Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective-Reference-Cited by-同舟云学术

Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective

Published:2017-06-26 Issue: Volume:7 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Kleinlützum Dina,Hanauer Julia D. S.,Muik Alexander,Hanschmann Kay-Martin,Kays Sarah-Katharina,Ayala-Breton Camilo,Peng Kah-Whye,Mühlebach Michael D.,Abel Tobias,Buchholz Christian J.

Funder

Deutsche Forschungsgemeinschaft

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference57 articles.

1. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways;Kahlert;Int J Cancer,2017

2. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell;Bonnet;Nat Med,1997

3. Identification of human brain tumour initiating cells;Singh;Nature,2004

4. CD133, selectively targeting the root of cancer;Schmohl;Toxins (Basel),2016

5. CD133: to be or not to be, is this the real question?;Irollo;Am J Transl Res,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells;Cell Biochemistry and Function;2024-06

2. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

3. Retrovirale Vektoren – Effiziente Gentaxis für unterschiedliche Gentherapien;Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft;2023-12-30

4. The role of oncolytic virotherapy and viral oncogenes in the cancer stem cells: a review of virus in cancer stem cells;Cancer Cell International;2023-10-25

5. CD90-targeted lentiviral vectors for HSC gene therapy;Molecular Therapy;2023-10